{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-23-000799","form_type":"8-K","ticker":null,"cik":"0001497504","company_name":"PLx Pharma Winddown Corp.","filed_at":"2023-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.060269+00:00","generated_at":"2026-06-14T12:51:00.350709+00:00","sec_items":["1.01","1.03","2.01","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"PLx Pharma Winddown Corp. completes sale of substantially all assets following Chapter 11 approval","bullets":["Sale to PLx Acquisition Company, LLC consummated on May 26, 2023, after Bankruptcy Court approval on May 25.","Company changed name to PLx Pharma Winddown Corp.; common stock trades on OTC Pink under PLXPQ.","Amendment to Asset Purchase Agreement clarified excluded assets, inventory definitions; Buyer Deficiency Claim eliminated.","Monthly operating reports filed for period April 13-30, 2023, covering initial bankruptcy period.","Company cautions trading in common stock is highly speculative; holders may receive no recovery."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-23-000799","json":"https://secwatch.observer/filing/0001193805-23-000799.json","markdown":"https://secwatch.observer/filing/0001193805-23-000799.md","text":"https://secwatch.observer/filing/0001193805-23-000799.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/e618671_8k-plx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T12:51:00.350709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bee891482020cb3c9c398434bdd5f9d6a01df275","claim":"PLx Pharma Winddown Corp. entered chapter 11 in United States Bankruptcy Court (petition 2023-05-26).","evidence_excerpt":"Item 1.03 Bankruptcy or Receivership. The information set forth under Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference.","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm","confidence":0.7,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 11"},{"label":"Court","value":"United States Bankruptcy Court"},{"label":"Petition","value":"2023-05-26"}],"fact_type":"distress_event"},{"claim_id":"8bf97f92c5ac31c4bcf6b5e272a967df55ba47d9","claim":"PLx Pharma Winddown Corp.: Company changed its name to 'PLx Pharma Winddown Corp.' (effective 2023-05-26).","evidence_excerpt":"On May 26, 2023, the Company filed an amendment to its Amended and Restated Certificate of Incorporation (the \"Charter Amendment\") with the Secretary of State of the State of Delaware in order to change its name to \"PLx Pharma Winddown Corp.\".","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-05-26"}],"fact_type":"governance_change"},{"claim_id":"c2b7144155693d80227f1fa132d32296058a914f","claim":"PLx Pharma Winddown Corp. completed a disposition involving PLx Acquisition Company, LLC (closed 2023-05-26).","evidence_excerpt":"Pursuant to the Asset Purchase Agreement, the Sale was consummated on May 26, 2023.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"PLx Acquisition Company, LLC"},{"label":"Closing","value":"2023-05-26"}],"fact_type":"ma_transaction"},{"claim_id":"1332c622be53defc4d3380bf5fd4932fecc5bc15","claim":"PLx Pharma Winddown Corp. amended Amendment No. 1 to the Asset Purchase Agreement with PLx Acquisition Company, LLC (effective 2023-05-26).","evidence_excerpt":"orse asset purchase agreement (the “Asset Purchase Agreement”) with PLx Acquisition Company, LLC, a wholly-owned subsidiary of Greenwood Brands, LLC (the “Purchaser”), to sell substantially all of the Sellers’ assets to the Purchaser pursuant","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1497504/000119380523000799/0001193805-23-000799-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"PLx Acquisition Company, LLC"},{"label":"Effective","value":"2023-05-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}